Semler Scientific, Inc. (NASDAQ:SMLR) Shares Sold by Bank of America Corp DE

Bank of America Corp DE reduced its position in Semler Scientific, Inc. (NASDAQ:SMLR) by 84.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,231 shares of the company’s stock after selling 27,407 shares during the period. Bank of America Corp DE’s holdings in Semler Scientific were worth $282,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in SMLR. Capital International Investors purchased a new position in Semler Scientific in the 4th quarter valued at about $30,813,000. Susquehanna Advisors Group Inc. purchased a new position in Semler Scientific in the 4th quarter valued at about $26,928,000. Thames Capital Management LLC purchased a new position in Semler Scientific in the 4th quarter valued at about $6,465,000. Invesco Ltd. purchased a new position in Semler Scientific in the 4th quarter valued at about $5,964,000. Finally, Principal Financial Group Inc. boosted its position in Semler Scientific by 633.1% in the 4th quarter. Principal Financial Group Inc. now owns 112,487 shares of the company’s stock valued at $6,074,000 after buying an additional 97,144 shares during the last quarter. 49.37% of the stock is owned by hedge funds and other institutional investors.

Semler Scientific Stock Performance

Shares of SMLR stock opened at $29.58 on Friday. Semler Scientific, Inc. has a one year low of $21.77 and a one year high of $81.56. The company’s 50-day simple moving average is $35.56 and its 200-day simple moving average is $45.61. The stock has a market capitalization of $329.88 million, a price-to-earnings ratio of 6.02 and a beta of 1.42.

Semler Scientific (NASDAQ:SMLR) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($0.76) EPS for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The company had revenue of $8.84 million for the quarter.

Analysts Set New Price Targets

Separately, Wall Street Zen cut shares of Semler Scientific from a “buy” rating to a “sell” rating in a research report on Thursday, May 22nd.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.